DK634589A - Acyloxypropanolaminer og deres anvendelse - Google Patents
Acyloxypropanolaminer og deres anvendelse Download PDFInfo
- Publication number
- DK634589A DK634589A DK634589A DK634589A DK634589A DK 634589 A DK634589 A DK 634589A DK 634589 A DK634589 A DK 634589A DK 634589 A DK634589 A DK 634589A DK 634589 A DK634589 A DK 634589A
- Authority
- DK
- Denmark
- Prior art keywords
- carbon atoms
- phenyl
- loweralkyl
- straight
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/12—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
- Processing Of Solid Wastes (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/285,008 US4935422A (en) | 1988-12-15 | 1988-12-15 | Acyloxypropanolamines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK634589D0 DK634589D0 (da) | 1989-12-14 |
| DK634589A true DK634589A (da) | 1990-06-16 |
Family
ID=23092348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK634589A DK634589A (da) | 1988-12-15 | 1989-12-14 | Acyloxypropanolaminer og deres anvendelse |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4935422A (da) |
| EP (1) | EP0373593B1 (da) |
| JP (1) | JPH02258750A (da) |
| AT (1) | ATE108765T1 (da) |
| AU (1) | AU639672B2 (da) |
| CA (1) | CA2005372A1 (da) |
| DE (1) | DE68916920T2 (da) |
| DK (1) | DK634589A (da) |
| FI (1) | FI895979A7 (da) |
| HU (1) | HU204025B (da) |
| IL (1) | IL92651A0 (da) |
| MY (1) | MY129948A (da) |
| NO (1) | NO895043L (da) |
| NZ (1) | NZ231753A (da) |
| PT (1) | PT92591B (da) |
| RU (1) | RU1776257C (da) |
| ZA (1) | ZA899621B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629345A (en) * | 1993-07-23 | 1997-05-13 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
| US5965620A (en) * | 1993-07-23 | 1999-10-12 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
| US7074828B2 (en) * | 2002-12-05 | 2006-07-11 | The Governors Of The University Of Alberta | Compounds that stimulate glucose utilization and methods of use |
| US7084173B2 (en) * | 2001-03-30 | 2006-08-01 | The Governors Of The Univerity Of Alberta | Compounds that stimulate glucose utilization and methods of use |
| EP1483283A4 (en) | 2002-03-13 | 2007-04-11 | Signum Biosciences Inc | MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE |
| US7524885B2 (en) * | 2002-04-01 | 2009-04-28 | The Governors Of The University Of Alberta | Compounds that stimulate glucose utilization and methods of use |
| US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| CA2601777A1 (en) * | 2005-02-03 | 2006-08-10 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| AU2009239430B2 (en) | 2008-04-21 | 2015-01-22 | Signum Biosciences, Inc. | Compounds, compositions and methods for making the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1161180A (en) * | 1979-09-10 | 1984-01-24 | David J. Schreck | Wet-adhesion aid |
| ZA827646B (en) * | 1981-11-12 | 1983-08-31 | American Hospital Supply Corp | Esters of aryloxypropanolamine derivatives |
| US4582855A (en) * | 1981-11-12 | 1986-04-15 | American Hospital Supply Corporation | Aromatic and esters of hydroxypropylamines |
| US4692446A (en) * | 1981-11-12 | 1987-09-08 | E. I. Du Pont De Nemours & Co., Inc. | Esters of aryloxypropanolamine derivatives and medicinal uses |
| US4959390A (en) * | 1988-12-15 | 1990-09-25 | E. I. Du Pont De Nemours And Company | Polyhydroxybenzyloxypropanolamines |
| US4897417A (en) * | 1988-12-15 | 1990-01-30 | E. I. Du Pont De Nemours & Co. | Prodrugs of 3,4-hydroxy benzoyloxypropanolamines |
| US4966914A (en) * | 1988-12-15 | 1990-10-30 | E. I. Du Pont De Nemours And Company | Oculoselective beta-blockers as antiglaucoma agents |
-
1988
- 1988-12-15 US US07/285,008 patent/US4935422A/en not_active Expired - Fee Related
-
1989
- 1989-12-12 DE DE68916920T patent/DE68916920T2/de not_active Expired - Fee Related
- 1989-12-12 AT AT89122923T patent/ATE108765T1/de not_active IP Right Cessation
- 1989-12-12 IL IL92651A patent/IL92651A0/xx unknown
- 1989-12-12 EP EP89122923A patent/EP0373593B1/en not_active Expired - Lifetime
- 1989-12-13 CA CA002005372A patent/CA2005372A1/en not_active Abandoned
- 1989-12-13 NZ NZ231753A patent/NZ231753A/en unknown
- 1989-12-14 DK DK634589A patent/DK634589A/da not_active Application Discontinuation
- 1989-12-14 NO NO89895043A patent/NO895043L/no unknown
- 1989-12-14 MY MYPI89001766A patent/MY129948A/en unknown
- 1989-12-14 FI FI895979A patent/FI895979A7/fi not_active Application Discontinuation
- 1989-12-14 RU SU894742927A patent/RU1776257C/ru active
- 1989-12-15 AU AU46797/89A patent/AU639672B2/en not_active Ceased
- 1989-12-15 ZA ZA899621A patent/ZA899621B/xx unknown
- 1989-12-15 HU HU896638A patent/HU204025B/hu not_active IP Right Cessation
- 1989-12-15 JP JP1324207A patent/JPH02258750A/ja active Pending
- 1989-12-15 PT PT92591A patent/PT92591B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE108765T1 (de) | 1994-08-15 |
| CA2005372A1 (en) | 1990-06-15 |
| HUT53592A (en) | 1990-11-28 |
| JPH02258750A (ja) | 1990-10-19 |
| FI895979A0 (fi) | 1989-12-14 |
| NO895043D0 (no) | 1989-12-14 |
| MY129948A (en) | 2007-05-31 |
| EP0373593A3 (en) | 1991-03-20 |
| PT92591B (pt) | 1995-09-12 |
| HU204025B (en) | 1991-11-28 |
| RU1776257C (ru) | 1992-11-15 |
| NO895043L (no) | 1990-06-18 |
| DE68916920T2 (de) | 1994-12-01 |
| PT92591A (pt) | 1990-06-29 |
| ZA899621B (en) | 1991-08-28 |
| DK634589D0 (da) | 1989-12-14 |
| AU4679789A (en) | 1990-06-21 |
| AU639672B2 (en) | 1993-08-05 |
| IL92651A0 (en) | 1990-08-31 |
| DE68916920D1 (de) | 1994-08-25 |
| EP0373593B1 (en) | 1994-07-20 |
| EP0373593A2 (en) | 1990-06-20 |
| NZ231753A (en) | 1991-07-26 |
| FI895979A7 (fi) | 1990-06-16 |
| US4935422A (en) | 1990-06-19 |
| HU896638D0 (en) | 1990-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU905826D0 (en) | Process for producing heterocyclic compounds | |
| ATE216584T1 (de) | Xanthine-derivate als antidepressiva | |
| NZ272015A (en) | Treatment of insufficiency of central choline functions using a cyclic amide (substituted 1,3-benzoxazin-2-one derivative) | |
| ATE162527T1 (de) | Piperazinderivate als 5-ht1a antagonisten. | |
| ATE250573T1 (de) | Azetidin- und pyrrolidinderivate | |
| DE69204717D1 (de) | ATP-Analogen. | |
| DK0683172T3 (da) | 11,21-bisphenyl-19-norpregnanderivater | |
| DK0565377T3 (da) | Terapeutiske midler til behandling af Parkinsons sygdom | |
| DE69111816D1 (de) | Indolederivate und ihre verwendung als serotonin-antagoniste. | |
| DK634589D0 (da) | Acyloxypropanolaminer og deres anvendelse | |
| DK384485A (da) | 1,6-naphthyridinderivater med kardilaterende virkning | |
| ES8504159A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1,2,5,-tidiazol. | |
| DK634189D0 (da) | Oculoselektive beta-blokkere og deres anvendelse | |
| EP0373591A3 (en) | Polyhydroxybenzyloxypropanolamines | |
| ATE58536T1 (de) | 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel. | |
| EP0649423A1 (en) | METHOD FOR PRODUCING 1,3-DIOXOLAN DERIVATIVES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |